Nisa Investment Advisors
OLMA icon

Nisa Investment Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Nisa Investment Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Sell
3,934
-1,930
-33% -$25.9K ﹤0.01% 1862
2026
Q1 		$87.4K Buy
5,864
+2,100
+56% +$46.7K ﹤0.01% 1474
2025
Q4 		$94.1K Buy
3,764
+477
+15% +$8.49K ﹤0.01% 1455
2025
Q3 		$32.2K Buy
3,287
+72
+2% +$432 ﹤0.01% 1783
2025
Q2 		$13.7K Buy
+3,215
New +$14.3K ﹤0.01% 2112
2025
Q1 		– Sell
-86
Closed -$501 – 3041
2024
Q4 		$501 Buy
86
+12
+16% +$120 ﹤0.01% 2832
2024
Q3 		$884 Buy
74
+16
+28% +$205 ﹤0.01% 2608
2024
Q2 		$628 Buy
58
+51
+729% +$553 ﹤0.01% 2636
2024
Q1 		$79 Sell
7
-33
-83% -$426 ﹤0.01% 2729
2023
Q4 		$561 Buy
+40
New +$537 ﹤0.01% 2384
2022
Q2 		– Sell
-31,400
Closed -$134K – 2471
2022
Q1 		$134K Buy
+31,400
New +$173K ﹤0.01% 1522

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Nisa Investment Advisors's OLMA Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Olema Pharmaceuticals (OLMA) stake by 33% in Q2 2026, selling an estimated $25.9K and leaving 3,934 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Nisa Investment Advisors first reported a position in OLMA in Q1 2022 and has held it in 11 quarters since. The position peaked at $134K in Q1 2022. 47 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Nisa Investment Advisors held 3,934 shares of Olema Pharmaceuticals worth $49.2K as of Q2 2026.
  • Nisa Investment Advisors sold 1,930 Olema Pharmaceuticals shares in Q2 2026, an estimated $25.9K.
  • Olema Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1862 holding.
  • Nisa Investment Advisors first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Olema Pharmaceuticals position peaked at $134K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.